Search results for "Cardiovascular risk"
MKSAP Quiz: Acute onset of vision loss
A 64-year-old man is evaluated in the emergency department for acute onset of vision loss in the left eye, which began 1 hour ago. He can barely see his own hands in front of his eye. He has no eye pain. Following a physical exam, eye exam, and lab studies, what is the most likely diagnosis?
https://immattersacp.org/archives/2019/07/mksap-quiz-acute-onset-of-vision-loss.htm
1 Jul 2019
Low-dose aspirin for primary prevention of CV events may only be effective in smaller people
The ability of 75 to 100 mg of aspirin to reduce cardiovascular events decreased with increasing weight, while doses of 325 mg or more had the opposite interaction with body weight, reducing cardiovascular events only in people who weighed more.
https://immattersacp.org/weekly/archives/2018/07/24/2.htm
24 Jul 2018
Pearls for lowering lipids
New guidelines recommend basing treatment decisions on levels of risk rather than LDL targets.
https://immattersacp.org/archives/2016/07/lipids.htm
1 Jul 2016
New psoriasis guidelines emphasize management of comorbidities, use of biologics
The guidelines cautioned that there is still limited evidence about long-term adverse events, impacts on future comorbidities, pediatric treatment, pregnancy and lactation, treatment combinations for newer biologics, and a need to identify biomarkers.
https://immattersacp.org/weekly/archives/2019/02/26/1.htm
26 Feb 2019
DTC screening tests a source of concern
With the proliferation of the number and scope of direct-to-consumer tests, ACP is concerned about the unnecessary costs and undue anxiety for patients when results lead to follow-up testing to rule out a medical concern.
https://immattersacp.org/archives/2018/06/dtc-screening-tests-a-source-of-concern.htm
1 Jun 2018
LABAs, LAMAs for COPD may be associated with increased CVD risk in first 30 days of use
Study authors caution physicians to closely monitor new users of long-acting beta2-agonists (LABAs) or long-acting antimuscarinic antagonists (LAMAs) for cardiovascular symptoms.
https://immattersacp.org/weekly/archives/2018/01/09/4.htm
9 Jan 2018
Combat cardiac risks of cancer therapies
One challenge of treating cancer is preventing, diagnosing, and treating heart failure in at-risk patients, and figuring out which patients would benefit from intervention.
https://immattersacp.org/archives/2018/09/combat-cardiac-risks-of-cancer-therapies.htm
1 Sep 2018
AHA releases scientific statement on cardiovascular health in African-American patients
Obesity, hypertension, and diabetes generally occur earlier in African-American patients than in white patients, and adverse health behaviors may partly explain the higher burden of risk factors for cardiovascular disease.
https://immattersacp.org/weekly/archives/2017/10/31/4.htm
31 Oct 2017
More options available for psoriatic arthritis
Internists are the first doctors patients see for joint pain, which means they can make a big difference in preventing the progression of joint diseases such as psoriatic arthritis.
https://immattersacp.org/archives/2019/04/more-options-available-for-psoriatic-arthritis.htm
1 Apr 2019
MKSAP Quiz: Cardiac risk assessment
A 58-year-old man is evaluated during a routine appointment and asks for advice on cardiac risk assessment. He does not have any current cardiac symptoms, exercises 4 days per week, and has never smoked. He has no chronic health issues and takes no medications. He has no known drug allergies. Results of the physical examination are normal. Following cardiovascular risk calculation, what test should be performed next?
https://immattersacp.org/weekly/archives/2016/04/05/3.htm
5 Apr 2016